Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.

Fasching, Patrizia, Stradner, Martin, Graninger, Winfried, Dejaco, Christian, Fessler, Johannes·2017·Molecules
DOI 10.3390/molecules22010134

Cites (202)

Items 201–202 of 202

  1. Interleukin 22, a Potential Therapeutic Target for Rheumatoid Arthritis
    Qiang Xie, Shi‐Cun Wang, ­Jun Li­ · 2012 · The Journal of Rheumatology
  2. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis
    Linbo Li, Wen Wen, Rulin Jia · 2016 · Clinical Rheumatology